The report includes information on TB disease reported from the 50 United States, the District of Columbia (DC), five U.S. territories (American Samoa, Commonwealth of the Northern Mariana Islands, Guam, Puerto Rico, and the U.S. Virgin Islands), and three independent countries that are in compacts of free association with the United States (Federated States of Micronesia, Republic of the Marshall Islands, and Republic of Palau).

The U.S. Centers for Disease Control and Prevention (CDC) has issued updated recommendations regarding the use of 3HP (once-weekly isoniazid-rifapentine for 12 weeks) for the treatment of latent tuberculosis (TB) infection. 

Earlier this year, the Centers for Disease Control and Prevention (CDC) released provisional 2015 surveillance data on reported tuberculosis (TB) cases in the United States. The full report, entitled Reported Tuberculosis in the United States, 2015, is now available online.

On 22 December 2015 the White House officially released a plan to address multidrug-resistant tuberculosis (MDR-TB) domestically and internationally and to advance research on this critical public health issue through a National Action Plan for Combating Multidrug-Resistant Tuberculosis.

Washington, DC –A Memorandum of Cooperation (MOC) signed today by U.S. Secretary of State John Kerry and Nkosazana Dlamini Zuma, M.B. Ch.B., chairperson of the African Union Commission, formalizes a collaboration between the African Union Commission and the U.S. Centers for Disease Control and Prevention in creating the African Centres for Disease Control and Prevention (African CDC).

Guidelines for managing pharmacologic interactions that can result when patients receive antiretroviral drugs for treatment of human immunodeficiency virus (HIV) infection together with rifamycin antibiotics for treatment of tuberculosis (TB) have been published previously (1–4). Newly updated guidelines, developed by CDC in collaboration with experts from other key national and international institutions, are now available at http://www.cdc.gov/tb/publications/guidelines/tb_hiv_drugs/default.htm.

In advance of World TB Day, the U.S. Centers for Disease Control and Prevention (CDC) released 2 new studies, one summarizing the latest national TB surveillance data for 2013, the second looking at the toll of drug-resistant TB in the U.S.

Cost to end deaths from childhood TB estimated to be at least US$120 million annually.

The World Health Organization, The Union, the Stop TB Partnership, USAID, CDC, the Treatment Action Group and UNICEF will launch a roadmap outlining the path towards zero deaths from childhood tuberculosis.

The strategy provides a clear definition of CDC's role in global health and will enable the agency to respond effectively to the evolving environment.